Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1460485
European Journal of Endocrinology, Vol 146, Issue 4, 485-490
Copyright © 2002 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Domingues, R
Right arrow Articles by Sobrinho, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Domingues, R
Right arrow Articles by Sobrinho, L

Case Reports

Two novel variants in the thyroxine-binding globulin (TBG) gene behind the diagnosis of TBG deficiency

R Domingues, MJ Bugalho, A Garrao, JM Boavida, and L Sobrinho

Centro de Investigacao de Patobiologia Molecular and Servico de Endocrinologia do Instituto Portugues de Oncologia de Lisboa, Lisbon, Portugal.

OBJECTIVE: Search for germline mutations in the thyroxine-binding globulin (TBG) gene of two unrelated Portuguese females of Caucasian origin in whom the diagnosis of TBG deficiency was suspected because of suppressed TSH despite marginally low total thyroxine and tri-iodothyronine. DESIGN AND METHODS: Screening for germline mutations was conducted by non-radioactive PCR-SSCP analysis. The variants documented by this approach were characterized by sequencing. Moreover, in order to define whether they were mutations or polymorphisms we looked for the same variants analysing 100 alleles at random. To achieve this goal we used, alternatively, restriction analysis and the minisequencing method with an automated capillary electrophoresis system and fluorescent-labelled dideoxynucleotides. RESULTS AND CONCLUSIONS: Two novel variants, one in each patient, were identified. One, involved codon 23 (TCA-->TAA) and the other, codon 223 (CAA-->TAA). Analysis of 50 DNA samples, randomly chosen, revealed that all were homozygous for the wild variant at codon 23. One of them was heterozygous for the variant CAA-->TAA at codon 223. This sample was found to correspond to a Caucasian female in whom serum TBG proved to be not detected. Since both variants identified result in stop codons likely to induce truncated TBG proteins, they are probably responsible for the TBG phenotype observed in the individuals studied.


This article has been cited by other articles:


Home page
EndocrinologyHome page
L. A. Zella, N. K. Shevde, B. W. Hollis, N. E. Cooke, and J. W. Pike
Vitamin D-Binding Protein Influences Total Circulating Levels of 1,25-Dihydroxyvitamin D3 but Does Not Directly Modulate the Bioactive Levels of the Hormone in Vivo
Endocrinology, July 1, 2008; 149(7): 3656 - 3667.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Fingerhut, S. Reutrakul, S. D. Knuedeler, L. C. Moeller, C. Greenlee, S. Refetoff, and O. E. Janssen
Partial Deficiency of Thyroxine-Binding Globulin-Allentown Is Due to a Mutation in the Signal Peptide
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2477 - 2483.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 European Society of Endocrinology.